Treatment of proctalgia fugax with botulinum toxin: Results in 5 patients;Tratamiento de la proctalgia fugax con toxina botulínica: Resultados en 5 pacientes

Revista Clinica Espanola

Volumn 206, Issue 3, 2006, Pages 137-140

  Sánchez Romero, Ana M ^a,b   Arroyo Sebastian A ^a   Perez Vicente F A ^a   Serrano Paz, P ^a   Candela Polo, F ^a   Calpena Rico, R ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b NONE   (Spain)

Author keywords

Botulinum A toxin; Proctalia fugax

Indexed keywords

BOTULINUM TOXIN A; CLONIDINE; DILTIAZEM; GLYCERYL TRINITRATE; NITRIC OXIDE; SALBUTAMOL;

ADULT; ANORECTAL PRESSURE; ANUS CONTINENCE; ANUS SPHINCTER; ARTICLE; BARIUM ENEMA; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL RECTAL EXAMINATION; DISEASE DURATION; DRUG EFFICACY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEALING; HUMAN; MALE; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PROCTALGIA; PROSPECTIVE STUDY; RECTOSCOPY; SCORING SYSTEM; SPAIN; UNIVERSITY HOSPITAL;

EID: 33646339911     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13086207     Document Type: Article

References (28)

1. Rao SS, Hatfield RA. Paroxysmal anal hyperkinesis: a characteristic feature of proctalgia fugax. Gut. 1996;39:609-12.
2. Katsinelos P, Kalomenopoulou M, Christodoulou K, Katsiba D, Tsolkas P, Pilpilidis I, et al. Treatment of proctalgia fugax with botulinum A toxin. Eur J Gastroenterol Hepatol. 2001;13:1371-3.
3. Thompson WG. Proctalgia fugax. Dig Dis Sci. 1981;26:1121-4.
4. Whitehead WE, Wald A, Diamant NE, Enc P, Pemberton JH, Rao SSC. Functional disorders of the anus and rectum. Gut. 1999;45 Suppl II:1155-9.
5. Heppell J. Surgery of the colon and rectum. London: Churchill Livingstone; 1997.
6. Thompson WG. Proctalgia fugax in patients with the irritable bowel, peptic ulcer, or inflammatory bocel disease. Am J Gastroenterol. 1984; 79:450-2.
7. Harvey RF. Colonic motility in proctalgia fugax. Lancet. 1979;2:713-4.
8. Sinaki M, Merrit JL, Stillwell GK. Tension myalgia of the pelvic floor. Mayo Clin Proc. 1977;52:717-22.
9. Kamm MA, Hoyle CH, Burleigh DE, Law PJ, Swash M, Martin JE, et al. Hereditary internal anal sphincter myopathy causing proctalgia fugax and constipation. A newly identified condition. Gastroenterology. 1991;100: 805-10.
10. Guy RJ, Kamm MA, Martin JE. Internal anal sphicter myopathy causing proctalgia fugax and constipation: further clinical and radiological characterization in a patient. Eur J Gastroenterol Hepatol. 1997;9:221-4.
11. Celik AF, Katsinelos P, Read NW, Khan MI, Donnelly TC. Hereditary proctalgia fugax and constipation: report of a second family. Gut. 1995; 36:581-4.
12. Lowenstein B, Cataldo PA. Treatment of proctalgia fugax with topical nitroglycerin: report of a case. Dis Colon Rectum. 1998;41:667-8.
13. Swain R. Oral clonidine for proctalgia fugax. Gut. 1987;28:1039-40.
14. Boquet J, Moore N, Lhuintre JP, Boismare F. Diltiazem for proctalgia fugax. Lancet. 1986;1:1493.
15. Eckardt VF, Dodt O, Kanzler G, Bernhard G. Treatment of proctalgia fugax with salbutamol inhalation. Am J Gastroenterol. 1996;91:686-9.
16. Hurst AF. Constipation and Allied Intestinal Disorders. London: Oxford University Press; 1909.
17. Douthwaite AH. Proctalgia fugax. BMJ. 1962;5298:164-5.
18. Dolly JO. Therapeutic and research exploitation of botulinum neurotoxina. Eur J Neurol. 1997;4 Suppl 2:S5-10.
19. Munchuau A, Bathia KP. Uses of botulinum toxin injection in medicine today. BMJ. 2000;320:161-5.
20. Mínguez M, Melo F, Espí A, García-Granero E, Mora F, Lledo S, et al. Therapeutics effects, of different doses of botulinum toxin in chronic anal fissure. Dis Colon Rectum. 1999;42:1016-21.
21. María G, Brisinda G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. Am J Surg. 2000;179:46-50.
22. Mínguez M, Herreros B, Espí A, Garc_iaca-Granero E, Sanchiz V, Mora F, Lledó S, Benages A, et al. Long-term follow-up (42 months) of chronic anal fissures after healing with botulinum toxin. Gastroenterology. 2002;123:112-7.
23. Arroyo A, Pérez F, Serrano P, Candela F, Lacueva J, Calpena R. Surgical versus chemical (botulinum toxin) sphincterotomy for chronic anal fissure: Long-term results of a prospective randomized clinical and manometric study. Am J Surg. 2005;189(4):429-34.
24. Arroyo A, Pérez F, Serrano P, Candela F, Calpena R. Long-term results of botulinum toxin for the treatment of chronic anal fissure: prospective clinical and manometric study. Int J Colorectal Dis. 2005;20(3):267-71.
25. Klein AW. Complications and adverse reactions with the use of botulinum toxin. Semin Cutan Med Surg. 2001;20:109-20.
26. McNamara MJ, Percy JP, Fielding IR. A manometric study of anal fissure treated by subcutaneus lateral internal sphincterotomy. Ann Surg. 1990;211:235-8.
27. Xynos E, Tzortzinis A, Chrysos E, Tzovaras G, Vassilakis JS. Anal manometry in patients with fissure in ano before and after internal sphincterotomy. Int J Colorect Dis. 1993;8:125-8.
28. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine E, Müller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut. 1999;45 Suppl II: 1143-7.